Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
|
Total |
Total The Joint Corp. Stockholders' Equity |
Common Stock |
Additional Paid-In Capital |
Treasury Stock |
Accumulated Deficit |
Non-controlling Interest |
| Balance, beginning common stock (in shares) at Dec. 31, 2024 |
|
|
15,192,893
|
|
|
|
|
| Balance, beginning at Dec. 31, 2024 |
$ 20,678,119
|
$ 20,653,119
|
$ 15,192
|
$ 49,210,455
|
$ (870,058)
|
$ (27,702,470)
|
$ 25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
33,015
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
293,941
|
293,941
|
|
293,941
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
148,565
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
0
|
$ 149
|
(149)
|
|
|
|
| Exercise of stock options (in shares) |
|
|
3,000
|
|
|
|
|
| Exercise of stock options |
905,976
|
905,976
|
$ 3
|
905,973
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
779
|
|
|
| Purchases of treasury stock under employee stock plans |
(8,440)
|
(8,440)
|
|
|
$ (8,440)
|
|
|
| Net income (loss) |
967,796
|
967,796
|
|
|
|
967,796
|
|
| Balance, ending common stock (in shares) at Mar. 31, 2025 |
|
|
15,344,458
|
|
|
|
|
| Balance, ending at Mar. 31, 2025 |
22,837,392
|
22,812,392
|
$ 15,344
|
50,410,220
|
$ (878,498)
|
(26,734,674)
|
25,000
|
| Balance, ending treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
33,794
|
|
|
| Balance, beginning common stock (in shares) at Dec. 31, 2024 |
|
|
15,192,893
|
|
|
|
|
| Balance, beginning at Dec. 31, 2024 |
20,678,119
|
20,653,119
|
$ 15,192
|
49,210,455
|
$ (870,058)
|
(27,702,470)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
33,015
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Purchases of treasury stock under employee stock plans |
(8,000)
|
|
|
|
|
|
|
| Net income (loss) |
1,916,168
|
|
|
|
|
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2025 |
|
|
15,433,861
|
|
|
|
|
| Balance, ending at Sep. 30, 2025 |
22,721,549
|
22,696,549
|
$ 15,433
|
51,634,910
|
$ (3,167,492)
|
(25,786,302)
|
25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2025 |
|
|
|
|
261,604
|
|
|
| Balance, beginning common stock (in shares) at Mar. 31, 2025 |
|
|
15,344,458
|
|
|
|
|
| Balance, beginning at Mar. 31, 2025 |
22,837,392
|
22,812,392
|
$ 15,344
|
50,410,220
|
$ (878,498)
|
(26,734,674)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
33,794
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
330,988
|
330,988
|
|
330,988
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
20,064
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
0
|
$ 20
|
(20)
|
|
|
|
| Net income (loss) |
93,363
|
93,363
|
|
|
|
93,363
|
|
| Balance, ending common stock (in shares) at Jun. 30, 2025 |
|
|
15,364,522
|
|
|
|
|
| Balance, ending at Jun. 30, 2025 |
23,261,743
|
23,236,743
|
$ 15,364
|
50,741,188
|
$ (878,498)
|
(26,641,311)
|
25,000
|
| Balance, ending treasury stock (in shares) at Jun. 30, 2025 |
|
|
|
|
33,794
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
346,209
|
346,209
|
|
346,209
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
(29,376)
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
0
|
$ (29)
|
29
|
|
|
|
| Exercise of stock options (in shares) |
|
|
98,715
|
|
|
|
|
| Exercise of stock options |
547,582
|
547,582
|
$ 98
|
547,484
|
|
|
|
| Purchases of treasury stock under employee stock plans |
0
|
|
|
|
|
|
|
| Common stock repurchased under authorized stock repurchase programs (in shares) |
|
|
|
|
227,810
|
|
|
| Common stock repurchased under authorized stock repurchase programs |
(2,288,994)
|
(2,288,994)
|
|
|
$ (2,288,994)
|
|
|
| Net income (loss) |
855,009
|
855,009
|
|
|
|
855,009
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2025 |
|
|
15,433,861
|
|
|
|
|
| Balance, ending at Sep. 30, 2025 |
$ 22,721,549
|
22,696,549
|
$ 15,433
|
51,634,910
|
$ (3,167,492)
|
(25,786,302)
|
25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2025 |
|
|
|
|
261,604
|
|
|
| Balance, beginning common stock (in shares) at Dec. 31, 2025 |
14,142,626
|
|
15,471,715
|
|
|
|
|
| Balance, beginning at Dec. 31, 2025 |
$ 15,079,592
|
15,054,592
|
$ 15,471
|
52,026,407
|
$ (12,192,081)
|
(24,795,205)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2025 |
1,329,089
|
|
|
|
1,329,089
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
$ 280,000
|
280,000
|
|
280,000
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
258,869
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
0
|
$ 259
|
(259)
|
|
|
|
| Exercise of stock options (in shares) |
|
|
9,058
|
|
|
|
|
| Exercise of stock options |
37,228
|
37,228
|
$ 9
|
37,219
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
5,822
|
|
|
| Purchases of treasury stock under employee stock plans |
(56,528)
|
(56,528)
|
|
|
$ (56,528)
|
|
|
| Common stock repurchased under authorized stock repurchase programs (in shares) |
|
|
|
|
137,088
|
|
|
| Common stock repurchased under authorized stock repurchase programs |
(1,145,054)
|
(1,145,054)
|
|
|
$ (1,145,054)
|
|
|
| Net income (loss) |
1,299,135
|
1,299,135
|
|
|
|
1,299,135
|
|
| Balance, ending common stock (in shares) at Mar. 31, 2026 |
|
|
15,739,642
|
|
|
|
|
| Balance, ending at Mar. 31, 2026 |
$ 15,494,373
|
15,469,373
|
$ 15,739
|
52,343,367
|
$ (13,393,663)
|
(23,496,070)
|
25,000
|
| Balance, ending treasury stock (in shares) at Mar. 31, 2026 |
|
|
|
|
1,471,999
|
|
|
| Balance, beginning common stock (in shares) at Dec. 31, 2025 |
14,142,626
|
|
15,471,715
|
|
|
|
|
| Balance, beginning at Dec. 31, 2025 |
$ 15,079,592
|
15,054,592
|
$ 15,471
|
52,026,407
|
$ (12,192,081)
|
(24,795,205)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2025 |
1,329,089
|
|
|
|
1,329,089
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Purchases of treasury stock under employee stock plans |
$ (77,000)
|
|
|
|
|
|
|
| Common stock repurchased under authorized stock repurchase programs |
(5,600,000)
|
|
|
|
|
|
|
| Net income (loss) |
$ 1,834,796
|
|
|
|
|
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2026 |
13,701,928
|
|
15,719,285
|
|
|
|
|
| Balance, ending at Sep. 30, 2026 |
$ 12,267,153
|
12,242,153
|
$ 15,719
|
53,102,139
|
$ (17,915,296)
|
(22,960,409)
|
25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2026 |
2,017,357
|
|
|
|
2,017,357
|
|
|
| Balance, beginning common stock (in shares) at Mar. 31, 2026 |
|
|
15,739,642
|
|
|
|
|
| Balance, beginning at Mar. 31, 2026 |
$ 15,494,373
|
15,469,373
|
$ 15,739
|
52,343,367
|
$ (13,393,663)
|
(23,496,070)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Mar. 31, 2026 |
|
|
|
|
1,471,999
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
423,180
|
423,180
|
|
423,180
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
16,323
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
0
|
$ 16
|
(16)
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
2,169
|
|
|
| Purchases of treasury stock under employee stock plans |
(18,455)
|
(18,455)
|
|
|
$ (18,455)
|
|
|
| Common stock repurchased under authorized stock repurchase programs (in shares) |
|
|
|
|
82,205
|
|
|
| Common stock repurchased under authorized stock repurchase programs |
(676,810)
|
(676,810)
|
|
|
$ (676,810)
|
|
|
| Net income (loss) |
653,021
|
653,021
|
|
|
|
653,021
|
|
| Balance, ending common stock (in shares) at Jun. 30, 2026 |
|
|
15,755,965
|
|
|
|
|
| Balance, ending at Jun. 30, 2026 |
15,875,309
|
15,850,309
|
$ 15,755
|
52,766,531
|
$ (14,088,928)
|
(22,843,049)
|
25,000
|
| Balance, ending treasury stock (in shares) at Jun. 30, 2026 |
|
|
|
|
1,556,373
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
335,572
|
335,572
|
|
335,572
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
(36,680)
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
0
|
$ (36)
|
36
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
220
|
|
|
| Purchases of treasury stock under employee stock plans |
(1,835)
|
(1,835)
|
|
|
$ (1,835)
|
|
|
| Common stock repurchased under authorized stock repurchase programs (in shares) |
|
|
|
|
460,764
|
|
|
| Common stock repurchased under authorized stock repurchase programs |
(3,824,533)
|
(3,824,533)
|
|
|
$ (3,824,533)
|
|
|
| Net income (loss) |
$ (117,360)
|
(117,360)
|
|
|
|
(117,360)
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2026 |
13,701,928
|
|
15,719,285
|
|
|
|
|
| Balance, ending at Sep. 30, 2026 |
$ 12,267,153
|
$ 12,242,153
|
$ 15,719
|
$ 53,102,139
|
$ (17,915,296)
|
$ (22,960,409)
|
$ 25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2026 |
2,017,357
|
|
|
|
2,017,357
|
|
|